(ANCN) |
| 0 (0%) 04-20 05:09 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 242.92 |
| Resistance 1: | 207.98 |
| Pivot price: | 194.03 |
| Support 1: | 189.14 |
| Support 2: | 177.50 |
| 52w High: | |
| 52w Low: |
| EPS | 12.190 |
| Book Value | 50.760 |
| PEG Ratio | 0.00 |
| Gross Profit | 37.610 |
| Profit Margin (%) | 10.61 |
| Operating Margin (%) | 13.82 |
| Return on Assets (ttm) | 11.2 |
| Return on Equity (ttm) | 24.8 |
Sun, 26 May 2024
Filannoo Afriikaa Kibbaa kan Itoophiyaanoti hedduun keessa jiraatan irratti qabxilee ijoo saddeeti - BBC
Thu, 11 Feb 2021
ANCN Stock: 10 Things to Know as Anchiano Therapeutics Rockets Higher - InvestorPlace
Tue, 15 Dec 2020
Anchiano Therapeutics jumps after Chemomab merger - גלובס
Thu, 09 May 2019
Filannoo Afriikaa Kibbaa: Filannoon cufamus qormaati ANC mudateera - BBC
Thu, 31 Jan 2019
ANCN IPO News - Micro-cap biotech Anchiano Therapeutics sets terms for $35 million US IPO - renaissancecapital.com
Wed, 14 Feb 2018
Zumaa Afrikaa Kibbaa: Manni maatii soreeyyii polisiin marfame - BBC
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |